Veru to Report Fiscal 2021 Third-Quarter Financial Results, Host Conference Call on August 12th
MIAMI, July 29, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing...
News
Albireo to Report Second Quarter 2021 Financial Results on August 5
— Conference call and webcast to be held at 10:00 a.m. ET —BOSTON, July 29, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma,...
Reminder: Acasti Pharma to Host Conference Call on August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics
LAVAL, Québec, July 29, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST)...
GBS Inc. to Present Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Update on August 11
- Company to Host Conference Call & Webcast at 4:30 p.m. ET -NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) --...
Guy Goodwin joins COMPASS Pathways as Chief Medical Officer
COMPASS announces changes to its Executive Team London, UK – 29 July 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a...
Quotient Limited to Report First Quarter Fiscal Year 2022 Financial Results and Host Conference Call
JERSEY, Channel Islands, July 29, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial...
Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth Conference
SAN DIEGO, July 29, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its...
Strongbridge Biopharma plc Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue
DUBLIN, Ireland and TREVOSE, Pa., July 29, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP) (“Strongbridge”), a global commercial-stage...
Palisade Bio and Newsoara Announce Positive Topline Efficacy Results from Phase 2 Study of LB1148 Demonstrating Accelerated Return of Bowel Function After Gastrointestinal Surgery
Statistically significant 1.1-day acceleration in return of bowel function Favorable overall safety profile in 120 patients CARLSBAD, Calif. and SHANGHAI,...
Aeterna Zentaris Receives Nasdaq Notification Regarding Minimum Bid Price Compliance; No Immediate Impact on Listing
CHARLESTON, S.C., July 29, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a...
Vivos Therapeutics Opens State of the Art International Training Center In Denver
The Vivos Institute Is Expected to Significantly Increase Vivos’ Ability to Educate Healthcare Providers on Ways to Help Millions of...
Alignment Healthcare Appoints Healthcare Veteran Afzal Shah to Lead Critical Medicare Advantage Market
ORANGE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Award-winning Medicare Advantage company Alignment Healthcare (NASDAQ: ALHC) today announced the appointment...
Augmenta Bioworks and TFF Pharmaceuticals Announce Positive In Vitro Data Demonstrating Binding and Neutralization of the SARS-CoV-2 Delta Variant by Lead Anti-COVID-19 Antibody, AUG-3387
Data Shows AUG-3387 Neutralizes SARS-CoV-2 Delta Variant in Infective Assays Supports Earlier Data Showing AUG-3387 Binds Strongly to Delta Variant...
Excision BioTherapeutics Appoints Industry Veteran Lisa Danzig, M.D., as Chief Medical Officer
SAN FRANCISCO, July 29, 2021 (GLOBE NEWSWIRE) -- Excision BioTherapeutics Inc, the developer of CRISPR-based therapies intended to cure viral...
Sensus Healthcare to Host Second Quarter 2021 Financial Results and Business Update Conference Call on August 5, 2021
BOCA RATON, Fla, July 29, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in...
CytomX Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021
SOUTH SAN FRANCISCO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company...
Arbutus to Report Second Quarter 2021 Financial Results and Provide Corporate Update
WARMINSTER, Pa., July 29, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on...
Caladrius Biosciences to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021 at 4:30 p.m. Eastern Time
BASKING RIDGE, N.J., July 29, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage...
Brickell Biotech to Report Second Quarter 2021 Financial Results and Provide a Corporate Update on August 12, 2021
BOULDER, Colo., July 29, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on...
Treatment.com unveils a new medical library to create the future of AI healthcare
VANCOUVER, British Columbia, July 29, 2021 (GLOBE NEWSWIRE) -- Treatment.com International Inc. “Treatment or The Company” (CSE: TRUE), a healthcare...